Abiomed Inc (NASDAQ:ABMD)

394.65
Delayed Data
As of 10:50am ET
 +0.19 / +0.05%
Today’s Change
134.39
Today|||52-Week Range
403.45
+110.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line37.4M24.5M13.4M--
 
 
 
 
Depreciation2.5M2.9M2.8M--
 
 
 
 
Total Other Cash Flow9.4M11.7M12.6M--
 
 
 
 
Funds From Operations45.4M46.0M60.4M--
 
 
 
 
Funds From/For Other Operating Expenses9.1M2.8M3.7M--
 
 
 
 
Net Cash Flow - Operating Activities36.3M43.2M56.7M--
 
 
 
 
 
InvestingIncrease In Investments-74.0M-64.3M-77.9M--
 
 
 
 
Decrease In Investments66.6M28.8M52.7M--
 
 
 
 
Capital Expenditures-9.8M-7.9M-26.5M--
 
 
 
 
Net Cash Flow Investing-17.2M-43.4M-51.7M--
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings----0.00----
Long Term Debt Reduction-184.0K-193.0K-140.0K--
 
 
 
 
Net Proceeds Stock Sale3.6M2.8M2.4M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends----------
Cash Dividends Paid - Total----------
Other Sources - Financing0.000.000.00----
Other Uses - Financing17.8M1.4M623.0K--
 
 
 
 
Net Cash Flow - Financing-14.4M1.1M1.6M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash278.0K-346.0K-622.0K--
 
 
 
 
 
Net Change In Cash4.7M912.0K6.6M0.00